Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Zhitong Pharmaceutical Group is a comprehensive pharmaceutical enterprise headquartered in Dingzhou, Hebei Province, China. The company integrates research and development, large-scale production, and domestic marketing of chemical drugs, biopharmaceuticals, and traditional Chinese medicines. Its product portfolio is particularly strong in the cardiovascular, cerebrovascular, and immunomodulatory therapeutic areas, featuring key products like Alprostadil and Thymopentin. Zhitong operates multiple GMP-certified production lines and has established itself as a significant player in the Chinese domestic market through its extensive distribution network and focus on high-quality generic and peptide-based therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Zhitong Pharmaceutical Group.